Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for FTRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2022. Start Trial.
Date Value
June 30, 2026 524.20M
March 31, 2026 525.90M
December 31, 2025 563.50M
September 30, 2025 580.80M
June 30, 2025 589.20M
March 31, 2025 858.80M
December 31, 2024 1.362B
September 30, 2024 1.514B
Date Value
June 30, 2024 1.461B
March 31, 2024 1.592B
December 31, 2023 1.714B
September 30, 2023 1.694B
June 30, 2023 1.751B
March 31, 2023 3.406B
December 31, 2022 3.343B

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Charles River Laboratories International, Inc. 2.840B
IQVIA Holdings, Inc. 6.171B
Medpace Holdings, Inc. 433.86M
Personalis, Inc. 235.16M
10X Genomics, Inc. 825.55M

Shareholders Equity (Quarterly) Related Metrics